This finding aligns with previous evidence that the effect of PNPLA3 on liver injury is stronger in patients with higher metabolic risk26 and that patients with DM carrying the PNPLA3 G-allele had higher circulating free fatty acid concentrations and greater adipose tissue insulin resistance than noncarriers33. This evidence concerns the gene PNPLA3 and Insulin resistance.